Clinical course of hyperprolactinemia in children and adolescents: A review of 21 cases

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 3, Issue 2, 2011, Pages 65-69

  Eren, Erdal ^a   Yapici, Fienay ^a   Çakir, Esra Deniz Papatya ^a   Ceylan, Latife Aytekin ^a   Saǧlam, Halil ^a   Tanm, Ömer ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Pituitary; Prolactin; Prolactinoma; Puberty

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ADOLESCENT; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; FEMALE; GALACTORRHEA; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS GONAD SYSTEM; MALE; MENSTRUATION DISORDER; MICROADENOMA; POSTOPERATIVE PERIOD; PROLACTINOMA; RECURRENCE RISK; RETROSPECTIVE STUDY; REVIEW; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; CHILD; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RETROSPECTIVE STUDIES; TURKEY;

EID: 79959224580     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.v3i2.14     Document Type: Review

References (19)

1. th ed. Blackwell Publishing. 2005;531-532.
2. Fideleff HL, Boquete HR, Sequera A, Suárez M, Sobrado P, Giaccio A. Peripubertal prolactinomas: clinical presentation and longterm outcome with different therapeutic approaches. J Pediatr Endocrinol Metab 2000;13:261-267.
3. Fideleff HL, Boquete HR, Suarez MG, Azaretzky M. Prolactinoma in Children and Adolescent. Horm Res 2009;72:197-205.
4. Vance ML. Hypopituitarism. N Engl J Med 1994;330:1651-1662.
5. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Ann Rev Physiol 2002;64:47-67.
6. Colao A, Loche S, Cappa M, Di Sarno A, Landi ML, Sarnacchiaro F, Facciolli G, Lombardi G. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998;83:2777-2780.
7. Kane LA, Leinung MC, Scheithauer BW, Bergstralh EJ, Laws ER Jr, Groover RV, Kovacs K, Horvath E, Zimmerman D. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994;79:1135-1140.
8. Saranac L, Zivanovic S, Radovanovic Z, Kostic G, Markovic I, Miljkovic P. Hyperprolactinemia: different clinical expression in childhood. Horm Res Paediatr 2010;73:187-192.
9. Wudarsky M, Nicolson R, Hamburger SD, Spechler L, Gochman P, Bedwell J, Lenane MC, Rapoport JL. Elevated prolactin in pediatric patients on typical and atypical antipsychotics. J Child Adolesc Psychopharmacol 1999;9:239-245.
10. Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006;45:771-791.
11. Vance ML, Evans WS, Thorner MO. Drugs five years later: bromocriptine. Ann Intern Med 1984;100:78-91.
12. Colao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 1997;82:3574-3579.
13. Kars M, Pereira AM, Smit JW, Romijn JA. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists. Eur J Intern Med 2009;20:387-393.
14. Iglesias P, Díez JJ. Complete remission of macroprolactinoma after long-term medical therapy with dopamine agonists. QJM 2010 Jul 27. [Epub ahead of print]
15. Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas J; HYPOPRONOS. Prognostic factors in prolactin pituitary tumors: clinical,histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 2010;95:1708-1716.
16. Hamilton DK, Vance ML, Boulos PT, Laws ER. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary 2005;8:53-60.
17. Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R, Buchfelder M. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 2008;158:11-18.
18. Acharya SV, Gopal RA, Bandgar TR, Joshi SR, Menon PS, Shah NS. Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary 2009;12:186-189.
19. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J Clin Endo Metab 2011;96:273-288.